FDA Human Factors Guidance 2026: Navigating New eSTAR Requirements

The US FDA has finalized its guidance on 'Content of Human Factors Information in Medical Device Marketing Submissions,' introducing a new risk-based framework that became mandatory within the eSTAR portal on August 1, 2026. This episode details the three new risk categories for Human Factors Engineering (HFE) and Usability Engineering (UE) data, explains how they impact 510(k), PMA, and De Novo submissions, and provides practical steps for manufacturers to adapt their processes and documentation to meet these updated requirements. Key Questions: - What is the FDA's finalized guidance on Human Factors for medical device submissions? - When did the new eSTAR template for Human Factors become mandatory? - How does the new risk-based framework categorize devices for HFE/UE data requirements? - What level of Human Factors data is required for a low-risk Category 1 device? - What are the submission requirements for moderate-risk Category 2 and high-risk Category 3 devices? - How should manufacturers update their internal HFE/UE processes to align with the new guidance? - What are the key changes to look for in the eSTAR portal's new Human Factors section? - How can regulatory teams perform a gap analysis against the finalized 2026 guidance? Sources: - https://www.fda.gov/regulatory-information/search-fda-guidance-documents/content-human-factors-information-medical-device-marketing-submissions - https://www.fda.gov/medical-devices/news-events-medical-devices/cdrh-new-news-and-updates - https://www.fdli.org/2026/06/fda-finalizes-human-factors-guidance-for-medical-device-marketing-submissions/ - https://www.raps.org/news-and-articles/news-articles/2026/5/fda-provides-additional-examples-clarity-in-huma How Pure Global can help: Pure Global provides comprehensive regulatory consulting for MedTech and IVD companies, streamlining global market access. We develop efficient regulatory strategies, manage technical dossier submissions using advanced AI, and act as your local representative in over 30 markets. Our experts can help you navigate complex requirements like the FDA's new Human Factors guidance, ensuring your submissions are compliant and minimizing delays. We support the entire product lifecycle, from initial strategy to post-market surveillance, helping you get to market faster and maintain compliance. For more information, visit https://pureglobal.com, contact us at [email protected], or explore our free AI tools and regulatory database at https://pureglobal.ai.